benzhexol ( 4-6 mg/day ) produced dramatic amelioration of symptoms , indicating a role for the cholinergic system in the pathophysiology of abnormal sensory symptoms in parkinson 's disease and possibly in human analgesia in general .
C0041009
benzhexol
C0030567
parkinson 's disease